REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 81 filers reported holding REVANCE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $803,000 | +2.3% | 29,130 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $785,000 | +42.7% | 29,730 | +12.5% | 0.00% | +50.0% |
| Q1 2017 | $550,000 | -11.4% | 26,430 | -11.8% | 0.00% | -33.3% |
| Q4 2016 | $621,000 | +21.3% | 29,977 | -5.0% | 0.00% | +50.0% |
| Q3 2016 | $512,000 | +12.3% | 31,556 | -6.0% | 0.00% | 0.0% |
| Q2 2016 | $456,000 | +53.0% | 33,556 | +96.5% | 0.00% | +100.0% |
| Q1 2016 | $298,000 | -48.4% | 17,079 | +1.2% | 0.00% | -50.0% |
| Q4 2015 | $577,000 | +26.0% | 16,878 | +9.7% | 0.00% | 0.0% |
| Q3 2015 | $458,000 | -6.9% | 15,381 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $492,000 | +50.0% | 15,381 | -2.9% | 0.00% | +100.0% |
| Q1 2015 | $328,000 | +4.5% | 15,845 | -14.6% | 0.00% | 0.0% |
| Q4 2014 | $314,000 | -15.1% | 18,559 | -3.1% | 0.00% | -50.0% |
| Q3 2014 | $370,000 | -39.6% | 19,150 | +6.2% | 0.00% | 0.0% |
| Q2 2014 | $613,000 | +28.8% | 18,030 | +19.3% | 0.00% | 0.0% |
| Q1 2014 | $476,000 | – | 15,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |